| For: | Tillmann HL. Hepatitis C virus core antigen testing: Role in diagnosis, disease monitoring and treatment. World J Gastroenterol 2014; 20(22): 6701-6706 [PMID: 24944462 DOI: 10.3748/wjg.v20.i22.6701] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6701.htm |
| Number | Citing Articles |
| 1 |
Mariia Antipchik, Jekaterina Reut, Akinrinade George Ayankojo, Andres Öpik, Vitali Syritski. MIP-based electrochemical sensor for direct detection of hepatitis C virus via E2 envelope protein. Talanta 2022; 250 doi: 10.1016/j.talanta.2022.123737
|
| 2 |
Anastasia Pechelyulko, Zhanna Andreeva-Kovalevskaya, Dmitriy Dmitriev, Viacheslav Lavrov, Yulia Massino, Alexey Nagel, Olga Segal, Olga S. Sokolova, Alexander Solonin, Yulia Tarakanova, Alexander Dmitriev. A simple method to purify recombinant HCV core protein expressed in Pichia pastoris for obtaining virus-like particles and producing monoclonal antibodies. Protein Expression and Purification 2021; 183 doi: 10.1016/j.pep.2021.105864
|
| 3 |
Samantha Jingyun Koh, Wei Lun Liou, Sheryl Gan, Pei Yun Liu, Chee Chin Phang, Wan Cheng Chow, Rajneesh Kumar. Moving Toward Hepatitis C Elimination in Haemodialysis: HCV Antigen as a Practical Screening Alternative. Cureus 2026; doi: 10.7759/cureus.108567
|
| 4 |
Irina Sominskaya, Juris Jansons, Anastasija Dovbenko, Natalia Petrakova, Ilva Lieknina, Marija Mihailova, Oleg Latyshev, Olesja Eliseeva, Irina Stahovska, Inara Akopjana, Ivars Petrovskis, Maria Isaguliants. Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5′ Terminus of Hepatitis C Virus RNA. Journal of Immunology Research 2015; 2015 doi: 10.1155/2015/762426
|
| 5 |
Sahaj Rathi, Radha K. Dhiman. Hepatobiliary Quiz (Answers)—16 (2015). Journal of Clinical and Experimental Hepatology 2015; 5(4) doi: 10.1016/j.jceh.2015.12.002
|
| 6 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 7 |
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2018; 18(8) doi: 10.1080/14737159.2018.1496020
|
| 8 |
Marjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, Raoel Maan, Johannes Vermehren, Benjamin Maasoumy, Tony Mazzulli, Shelly Bolotin, Gary Garber, Fiona Guerra, Christopher R Flud, Matthew Kowgier, Harry L Janssen, Robert J de Knegt, Jean-Michel Pawlotsky, Gavin A Cloherty, Andres Duarte-Rojo, Christoph Sarrazin, Heiner Wedemeyer, Jordan J Feld. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies. The Lancet Gastroenterology & Hepatology 2018; 3(12) doi: 10.1016/S2468-1253(18)30271-1
|
| 9 |
Müge Toygar Deniz, Sıla Akhan, Murat Sayan, Gülden Sönmez Tamer, Emel Azak. Evaluation of HCV-Core Antigen in Diagnosis of Chronic Hepatitis C Patients under Direct-Acting Antiviral Treatment. Viral Hepatitis Journal 2022; 28(1) doi: 10.4274/vhd.galenos.2022.2021-3-2
|
| 10 |
Alessio Aghemo, Elisabetta Degasperi, Stella De Nicola, Patrizia Bono, Anna Orlandi, Roberta D’Ambrosio, Roberta Soffredini, Riccardo Perbellini, Giovanna Lunghi, Massimo Colombo. Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection. Clinical Gastroenterology and Hepatology 2016; 14(9) doi: 10.1016/j.cgh.2016.03.035
|
| 11 |
Amr S. Hanafy, Waseem M. Seleem, Mohammad A.A. Basha, Ayman M. Marei. Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction. European Journal of Gastroenterology & Hepatology 2019; 31(10) doi: 10.1097/MEG.0000000000001459
|
| 12 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; doi: 10.1128/9781555819040.ch3
|
| 13 |
Moataz M. Sayed, Ahmed I. El-Shafie, Ahmed Fathy Hilal, Hoda A. Abdelsattar. Can hepatitis C virus core antigen be used as a reliable marker of viral load for hepatitis C virus infection in genotype 4?. Egyptian Liver Journal 2017; 7(1 and 2) doi: 10.1097/01.ELX.0000523559.96944.09
|
| 14 |
Xue Z. Wong, Azzeri Amirah, Chye C. Gan, Shabaruddin Fatiha, Dahlui Maznah, Rosnawati Yahya, Shubash Ganapathy, Soek S. Tan, Rosmawati Mohamed, Soo K. Lim. Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications. Nephrology 2021; 26(5) doi: 10.1111/nep.13862
|
| 15 |
Jeffrey V. Lazarus, Daniel J. Bromberg, Julia del Amo, Ole Norgaard, Javier García-Samaniego, Aina Casellas, José Luis Calleja, Ana Requena-Méndez. Hepatitis C prevalence among the migrant population in Spain: A systematic review and meta-analysis. Enfermedades Infecciosas y Microbiología Clínica 2019; 37(4) doi: 10.1016/j.eimc.2018.04.002
|
| 16 |
Andrea Galli, Santseharay Ramirez, Jens Bukh. Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1–3 Strains and Does Not Correlate with Virus Replication. Viruses 2021; 13(3) doi: 10.3390/v13030389
|
| 17 |
Sheng Feng Lin, Shui-Yi Tung, Kuo-Liang Wei, Chien-Hung Chen, Tsung-Hui Hu, Chien Heng Shen, Te-Sheng Chang, Wei-Ming Chen, Chih-Wei Yen, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chen-Hua Liu. Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. PLOS ONE 2020; 15(3) doi: 10.1371/journal.pone.0229994
|
| 18 |
Federico Hinestrosa, Juan Ignacio Marín, Octavio Muñoz Maya, Oscar Santos, Juan Carlos Restrepo. Update of Hepatitis C in Colombia. Current Tropical Medicine Reports 2018; 5(3) doi: 10.1007/s40475-018-0147-5
|
| 19 |
Hannah Evans, Sooria Balasegaram, Sam Douthwaite, Laura Hunter, Ranjababu Kulasegaram, Terry Wong, Antonio Querol-Rubiera, Gaia Nebbia, Isabelle Chemin. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department. PLOS ONE 2018; 13(7) doi: 10.1371/journal.pone.0198520
|
| 20 |
Yuhan Wang, Wang Jie, Jiang Ling, Huang Yuanshuai. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV‐RNA detection. Journal of Clinical Laboratory Analysis 2021; 35(6) doi: 10.1002/jcla.23755
|
| 21 |
Mariusz Łucejko, Robert Flisiak. Quantitative Measurement of HCV Core Antigen for Management of Interferon-Free Therapy in HCV-Infected Patients. Antiviral Therapy 2018; 23(2) doi: 10.3851/IMP3190
|
| 22 |
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015. Journal of Clinical and Experimental Hepatology 2015; 5(3) doi: 10.1016/j.jceh.2015.09.002
|
| 23 |
Claudio Galli, Paul Julicher, Mario Plebani. HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection. Clinical Chemistry and Laboratory Medicine (CCLM) 2018; 56(6) doi: 10.1515/cclm-2017-0754
|
| 24 |
Bashar M Attar, David H Van Thiel. Hepatitis C virus: A time for decisions. Who should be treated and when?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 33-40 doi: 10.4292/wjgpt.v7.i1.33
|
| 25 |
Poonam Mathur, Shyam Kottilil. Hepatitis C Core Antigen Testing: Still an Effective Diagnostic Method for Global Elimination of Hepatitis C. Clinical Infectious Diseases 2020; 70(4) doi: 10.1093/cid/ciz273
|
| 26 |
Mi Na Kim, Hyon-Suk Kim, Ja Kyung Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han. Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C. Journal of Korean Medical Science 2016; 31(9) doi: 10.3346/jkms.2016.31.9.1431
|
| 27 |
Alejandra Pérez-García, Aitziber Aguinaga, Ana Navascués, Jesús Castilla, Carmen Ezpeleta. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus. International Journal of Infectious Diseases 2019; 89 doi: 10.1016/j.ijid.2019.09.022
|
| 28 |
Jeffrey V. Lazarus, Daniel J. Bromberg, Julia del Amo, Ole Norgaard, Javier García-Samaniego, Aina Casellas, José Luis Calleja, Ana Requena-Méndez. Hepatitis C prevalence among the migrant population in Spain: A systematic review and meta-analysis. Enfermedades infecciosas y microbiologia clinica (English ed.) 2019; 37(4) doi: 10.1016/j.eimce.2018.04.021
|
| 29 |
S. Pischke, S. Polywka, V.M. Proske, M. Lang, S. Jordan, B. Nashan, A.W. Lohse, M. Sterneck. Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real‐life setting. Transplant Infectious Disease 2016; 18(1) doi: 10.1111/tid.12475
|
| 30 |
Rafael Benito, Jorge Arribas, Sonia Algarate, Rocío Cebollada, M. José Gude. Hepatitis C virus core antigen for screening organ donors and recipients. Diagnostic Microbiology and Infectious Disease 2018; 91(2) doi: 10.1016/j.diagmicrobio.2018.01.021
|
| 31 |
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantation. Nature Reviews Nephrology 2015; 11(3) doi: 10.1038/nrneph.2015.5
|
| 32 |
Zhijuan Fan, Junfeng Liu, Fengmei Wang, Jingmin Liu, Xian Ding, Shuye Liu. HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b. Medicine 2019; 98(10) doi: 10.1097/MD.0000000000014795
|
| 33 |
Philippa J. Easterbrook. Who to test and how to test for chronic hepatitis C infection – 2016 WHO testing guidance for low- and middle-income countries. Journal of Hepatology 2016; 65(1) doi: 10.1016/j.jhep.2016.08.002
|
| 34 |
Juan Carlos Alados Arboledas, Inmaculada Pavón Guerrero, María José Blanco Rodríguez, Eva Torres Martos, Ana Belén Pérez, Cristina Cepero León, Jesus F. Sierra Sánchez, María Dolores López Prieto, Natalia Chueca Porcuna, María Dolores Ocete Mochón, Juan Macías, Alberto de la Iglesia Salgado, Javier Rodríguez Granger, Marcial Delgado Fernández, Inmaculada Guerrero Lozano, Elena Reigadas Ramírez, Antonio Rivero, María del Carmen Lozano Domínguez, Isabel Viciana, Juan Carlos Galán Montemayor, Federico García García. Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals. Diagnostic Microbiology and Infectious Disease 2017; 89(1) doi: 10.1016/j.diagmicrobio.2017.06.006
|
| 35 |
Vigneswaran Narayanamurthy, Z. E. Jeroish, K. S. Bhuvaneshwari, Fahmi Samsuri. Hepatitis C virus (HCV) diagnosis via microfluidics. Analytical Methods 2021; 13(6) doi: 10.1039/D0AY02045A
|
| 36 |
Sudip Nepal, Erik D. Holmstrom, J.-H. James Ou. Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein. Journal of Virology 2023; 97(10) doi: 10.1128/jvi.00892-23
|
| 37 |
Miguel Bosch, Adriana Moreno, Raul Colmenares, Jose Arocha, Sina Hoche, Auris Garcia, Daniela Hall, Dawlyn Garcia, Lindsey Rudtner, Nol Salcedo, Irene Bosch. Estimating Antigen Test Sensitivity via Target Distribution Balancing: Development and Validation Study. JMIR Bioinformatics and Biotechnology 2025; 6 doi: 10.2196/68476
|
| 38 |
Hiroko Setoyama, Takehisa Watanabe, Shiho Miyase, Masakuni Tateyama, Motohiko Tanaka, Nobuhiro Minami, Masato Sasaki, Shunpei Hashigo, Kotaro Fukubayashi, Shotaro Ishii, Mutsuo Koga, Ryo Ichikawa, Hirofumi Iwashita, Yoshinari Sakai, Toshihiko Motohara, Kohei Tomita, Akinori Nakata, Yutaka Kai, Takeyasu Kounoe, Katsuki Haraoka, Takako Inoue, Takanori Suzuki, Kentaro Matsuura, Yasuhito Tanaka. Improving Linkage to the HCV Care Cascade in Nonspecialist Settings: Evaluation of the Performance and Triage Utility of the Elecsys HCV Duo Assay in Japan. Journal of Clinical Laboratory Analysis 2026; doi: 10.1002/jcla.70286
|
| 39 |
Paul Jülicher, Vladimir P. Chulanov, Nikolay N. Pimenov, Ekaterina Chirkova, Anna Yankina, Claudio Galli, Hans Tillmann. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis. PLOS ONE 2019; 14(7) doi: 10.1371/journal.pone.0219687
|
| 40 |
Young Jun Kim, Won-Yeop Rho, Seung-min Park, Bong-Hyun Jun. Optical nanomaterial-based detection of biomarkers in liquid biopsy. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01531-y
|
| 41 |
Xue Zheng Wong, Chye Chung Gan, Rosmawati Mohamed, Rosnawati Yahya, Shubash Ganapathy, Soek Siam Tan, Soo Kun Lim. Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-02154-4
|
| 42 |
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections. 2020; doi: 10.1007/978-3-030-02200-6_6
|
| 43 |
A. Cassedy, A. Parle-McDermott, R. O’Kennedy. Virus Detection: A Review of the Current and Emerging Molecular and Immunological Methods. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.637559
|
| 44 |
David M. Brett‐Major, Kevin D. Frick, Jennifer A. Malia, Shilpa Hakre, Jason F. Okulicz, Charmagne G. Beckett, Linda L. Jagodinski, Michael A. Forgione, Philip L. Gould, Stephen A. Harrison, Clinton K. Murray, Francisco J. Rentas, Adam W. Armstrong, Aatif M. Hayat, Laura A. Pacha, Peter Dawson, Angelia A. Eick‐Cost, Hala H. Maktabi, Nelson L. Michael, Steven B. Cersovsky, Sheila A. Peel, Paul T. Scott. Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies. Hepatology 2016; 63(2) doi: 10.1002/hep.28303
|
| 45 |
Sonia Arca-Lafuente, Cristina Casanueva-Benítez, Celia Crespo-Bermejo, Violeta Lara-Aguilar, Luz Martín-Carbonero, Ignacio de los Santos, Ricardo Madrid, Verónica Briz. 903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNA. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14375-8
|
| 46 |
Taha M. Hassanin, Ehab M. Abdelraheem, Saad Abdelhameed, Mohamed Abdelrazik, Yasser M. Fouad. Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody. European Journal of Gastroenterology & Hepatology 2020; 32(10) doi: 10.1097/MEG.0000000000001647
|
| 47 |
Tamer A. Elbedewy, Rasha A. Elkholy, Eslam Habba, Sarah Ragab Abd El-Khalik. Occult hepatitis C in peripheral blood mononuclear cells in thrombocytopenic patients after achieving sustained virological response with direct-acting antivirals. The Egyptian Journal of Haematology 2021; 46(2) doi: 10.4103/ejh.ejh_60_20
|
| 48 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 49 |
M Łucejko, K Tomasiewicz, A Olczak, M Tudrujek-Zdunek, W Halota, W Jelski, H Donica, M Krintus, B Mroczko, R Flisiak. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals. British Journal of Biomedical Science 2019; 76(4) doi: 10.1080/09674845.2019.1654790
|
| 50 |
Mariia Antipchik, Evgenia Korzhikova-Vlakh, Dmitry Polyakov, Irina Tarasenko, Jekaterina Reut, Andres Öpik, Vitali Syritski. An electrochemical biosensor for direct detection of hepatitis C virus. Analytical Biochemistry 2021; 624 doi: 10.1016/j.ab.2021.114196
|
| 51 |
Ning Zhao, Wei Zheng, Dan Wu, Xuelian Wang, Wei Yang, Lin Yuan, Zhiqiang Niu, Xiaodi Jiang, Fen Huang, Zhiwei Li. Clinical value of hepatitis C virus core antigen levels in monitoring acute hepatitis C spontaneous clearance or treatment‐induced clearance. Journal of Medical Virology 2018; 90(12) doi: 10.1002/jmv.25256
|
| 52 |
Maryam Sadeghimehr, Barbara Bertisch, Francesco Negro, Maia Butsashvili, Sonjelle Shilton, Irina Tskhomelidze, Maia Tsereteli, Olivia Keiser, Janne Estill. Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis. PeerJ 2021; 9 doi: 10.7717/peerj.11895
|
| 53 |
Monica Desai, Ellen White, Nina Vora, Richard Gilson, Charles Lacey, Mitzy Gafos, Amanda Clarke, Ann Sullivan, David White, Julie Fox, David Piontkowsky, Sheena McCormack, David T. Dunn. High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre‐exposure prophylaxis. Journal of Viral Hepatitis 2020; 27(8) doi: 10.1111/jvh.13297
|
| 54 |
Lijuan Wang, Hong Lv, Guojun Zhang. Hepatitis C virus core antigen assay: an alternative method for hepatitis C diagnosis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2017; 54(2) doi: 10.1177/0004563216661218
|
| 55 |
Sonia Arca-Lafuente, Paula Martínez-Román, Irene Mate-Cano, Ricardo Madrid, Verónica Briz. Nanotechnology: A reality for diagnosis of HCV infectious disease. Journal of Infection 2020; 80(1) doi: 10.1016/j.jinf.2019.09.010
|
| 56 |
Linh Thuy Nguyen, Emma Gray, Aisling O'Leary, Michael Carr, Cillian F. De Gascun, Wenzhe Ho. The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors. PLOS ONE 2016; 11(10) doi: 10.1371/journal.pone.0163900
|
| 57 |
Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Chompoonut Auphimai, Nipaporn Siripon, Sirapa Klinfueng, Pisit Tangkijvanich, Sompong Vongpunsawad, Yong Poovorawan. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs. PeerJ 2017; 5 doi: 10.7717/peerj.4008
|
| 58 |
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. Journal of Clinical and Experimental Hepatology 2016; 6(2) doi: 10.1016/j.jceh.2016.07.001
|
| 59 |
Giovanni Di Minno, Carlo Federico Perno, Andreas Tiede, David Navarro, Mariana Canaro, Lutz Güertler, James W. Ironside. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders. Blood Reviews 2016; 30(1) doi: 10.1016/j.blre.2015.07.004
|